Evan Shlofmitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evan Shlofmitz has a total of 441 co-authors. Here are the top co-authors by number of shared publications:
Richard Shlofmitz
Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York
29 shared publications- Michael S. Lee
UCLA Medical Center, Los Angeles, California
25 shared publications - Ron Waksman
Section of Interventional Cardiology MedStar Washington Hospital Center Washington DC USA
25 shared publications Nauman Khalid
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia
21 shared publicationsPerwaiz Meraj
21 shared publicationsYuefeng Chen
20 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Cardiovascular Intervention
- Vol. 6
Contemporary Management of Calcified Coronary Lesions: An Imaging-Guided Practical Approach
Shin D, et al. J Cardiovasc Interv. 2027 ;6:e6. https://doi.org/10.54912/jci.2026.0036
- 1 January 2027
- Published by XMLink in Journal of Cardiovascular Intervention
- Vol. 6
Open AccessContemporary Management of Calcified Coronary Lesions: An Imaging-Guided Practical Approach
Shin D, et al. J Cardiovasc Interv. 2027 ;6:e6. https://doi.org/10.54912/jci.2026.0036
- Open Access
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e049353
Real‐World External Validation of Artificial Intelligence‐Based Full‐Vessel Segmentation for Intracoronary Optical Coherence Tomography
Background: Artificial intelligence (AI) allows automated evaluation of intracoronary optical coherence tomography (OCT) images. However, algorithms are mostly developed and validated on well‐curated data sets, which may not represent real‐world data. We sought to externally validate a previously developed algorithm performing full‐vessel segmentation for OCT in an unselected consecutive real‐world data set. Methods: This was a retrospective, single‐center, external validation study comprising 100 consecutive patients undergoing clinically indicated OCT. A previously developed AI algorithm (OCT‐AID) was used for automated pixelwise labeling of OCT images, distinguishing among lumen, guidewire artifact, intima, media, lipid plaque, calcium plaque, side branch, plaque rupture, thrombus, microvessel, and background. The AI‐based predictions were compared on a frame level to the reference standard obtained through manual OCT image analysis by expert readers. Results: Among 2560 analyzable frames, the agreement between the automated OCT image analysis and the reference standard was excellent for calcified plaque identification (κ=0.88 [95% CI, 0.84–0.92]) and quantification (intraclass correlation coefficient values ranged between 0.79 and 0.93), with a performance close to interobserver variability. For lipid plaque identification and quantification, the model performance was reasonable (κ=0.68 [95% CI, 0.64–0.72]; intraclass correlation coefficient for lipid arc, 0.79 [95% CI, 0.76–0.81]; intraclass correlation coefficient for minimum fibrous cap thickness, 0.59 [95% CI, 0.55–0.63]) and largely superior to interobserver variability. The algorithm performance for low‐prevalence features (e.g., plaque rupture) was limited. Conclusions: AI‐based fully automated evaluation of OCT images is feasible with performances consistent with interobserver variability in a real‐world data set of consecutive patients, supporting generalizability of the proposed methodology.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e049353
Open AccessReal‐World External Validation of Artificial Intelligence‐Based Full‐Vessel Segmentation for Intracoronary Optical Coherence Tomography
Background: Artificial intelligence (AI) allows automated evaluation of intracoronary optical coherence tomography (OCT) images. However, algorithms are mostly developed and validated on well‐curated data sets, which may not represent real‐world data. We sought to externally validate a previously developed algorithm performing full‐vessel segmentation for OCT in an unselected consecutive real‐world data set. Methods: This was a retrospective, single‐center, external validation study comprising 100 consecutive patients undergoing clinically indicated OCT. A previously developed AI algorithm (OCT‐AID) was used for automated pixelwise labeling of OCT images, distinguishing among lumen, guidewire artifact, intima, media, lipid plaque, calcium plaque, side branch, plaque rupture, thrombus, microvessel, and background. The AI‐based predictions were compared on a frame level to the reference standard obtained through manual OCT image analysis by expert readers. Results: Among 2560 analyzable frames, the agreement between the automated OCT image analysis and the reference standard was excellent for calcified plaque identification (κ=0.88 [95% CI, 0.84–0.92]) and quantification (intraclass correlation coefficient values ranged between 0.79 and 0.93), with a performance close to interobserver variability. For lipid plaque identification and quantification, the model performance was reasonable (κ=0.68 [95% CI, 0.64–0.72]; intraclass correlation coefficient for lipid arc, 0.79 [95% CI, 0.76–0.81]; intraclass correlation coefficient for minimum fibrous cap thickness, 0.59 [95% CI, 0.55–0.63]) and largely superior to interobserver variability. The algorithm performance for low‐prevalence features (e.g., plaque rupture) was limited. Conclusions: AI‐based fully automated evaluation of OCT images is feasible with performances consistent with interobserver variability in a real‐world data set of consecutive patients, supporting generalizability of the proposed methodology.
- 29 October 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (6) , 658-664
Photon-counting detector computed tomography for evaluation of coronary artery disease in older adults
- 29 October 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (6) , 658-664
Photon-counting detector computed tomography for evaluation of coronary artery disease in older adults
- 1 October 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (10) , e015254
Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules
BACKGROUND: Calcified nodules (CNs) remain a major challenge in percutaneous coronary intervention (PCI). We sought to compare procedural and clinical outcomes after orbital atherectomy (OA) versus intravascular lithotripsy (IVL)-facilitated PCI in patients with CNs. METHODS: We identified patients with optical coherence tomography (OCT)-defined CNs who underwent PCI with either OA or IVL between 2012 and 2022 and had both pre- and post-PCI OCT images available. The imaging end point was the minimal stent area on final post-PCI OCT. The clinical end point was 2-year target-lesion failure, a composite of cardiac death, target-vessel myocardial infarction, or clinically driven target-lesion revascularization. A multivariable Cox proportional hazards regression model was used to estimate hazard ratio and 95% CI. Sensitivity analyses were performed using propensity score matching, incorporating covariates such as age, sex, diabetes, and pre-PCI calcium burden assessed by OCT (length, arc, and thickness). RESULTS: Among 4856 patients with evaluable pre- and post-PCI OCT images, 493 patients (10.2%) had CNs, and 167 patients underwent PCI with either OA (n=83) or IVL (n=84). The 2 groups had similar baseline demographic and lesion characteristics. After PCI, final minimal stent area was comparable between the 2 groups (OA, 5.6 mm 2 [interquartile range, 4.8–6.7] versus IVL, 5.5 mm 2 [interquartile range, 4.8–7.0]; P =0.75). At a median follow-up of 2.4 years, there was no difference in target-lesion failure between the OA and IVL groups (12.0% versus 9.8%, respectively; log-rank P =0.64; adjusted hazard ratio, 1.10 [95% CI, 0.28–4.31]; P =0.89). Overall results remained consistent in the propensity score-matched population (n=68 per group), with similar minimal stent area (5.6 mm 2 [4.8–6.7] versus 5.5 mm 2 [4.7–6.8]; P =0.73) and comparable 2-year target-lesion failure rate (9.8% versus 8.8%; log-rank P =0.82). CONCLUSIONS: In patients with OCT-defined CNs, OA- and IVL-assisted PCI resulted in comparable post-PCI minimal stent area and 2-year clinical outcomes.
- 1 October 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (10) , e015254
Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules
BACKGROUND: Calcified nodules (CNs) remain a major challenge in percutaneous coronary intervention (PCI). We sought to compare procedural and clinical outcomes after orbital atherectomy (OA) versus intravascular lithotripsy (IVL)-facilitated PCI in patients with CNs. METHODS: We identified patients with optical coherence tomography (OCT)-defined CNs who underwent PCI with either OA or IVL between 2012 and 2022 and had both pre- and post-PCI OCT images available. The imaging end point was the minimal stent area on final post-PCI OCT. The clinical end point was 2-year target-lesion failure, a composite of cardiac death, target-vessel myocardial infarction, or clinically driven target-lesion revascularization. A multivariable Cox proportional hazards regression model was used to estimate hazard ratio and 95% CI. Sensitivity analyses were performed using propensity score matching, incorporating covariates such as age, sex, diabetes, and pre-PCI calcium burden assessed by OCT (length, arc, and thickness). RESULTS: Among 4856 patients with evaluable pre- and post-PCI OCT images, 493 patients (10.2%) had CNs, and 167 patients underwent PCI with either OA (n=83) or IVL (n=84). The 2 groups had similar baseline demographic and lesion characteristics. After PCI, final minimal stent area was comparable between the 2 groups (OA, 5.6 mm 2 [interquartile range, 4.8–6.7] versus IVL, 5.5 mm 2 [interquartile range, 4.8–7.0]; P =0.75). At a median follow-up of 2.4 years, there was no difference in target-lesion failure between the OA and IVL groups (12.0% versus 9.8%, respectively; log-rank P =0.64; adjusted hazard ratio, 1.10 [95% CI, 0.28–4.31]; P =0.89). Overall results remained consistent in the propensity score-matched population (n=68 per group), with similar minimal stent area (5.6 mm 2 [4.8–6.7] versus 5.5 mm 2 [4.7–6.8]; P =0.73) and comparable 2-year target-lesion failure rate (9.8% versus 8.8%; log-rank P =0.82). CONCLUSIONS: In patients with OCT-defined CNs, OA- and IVL-assisted PCI resulted in comparable post-PCI minimal stent area and 2-year clinical outcomes.
- Open Access
- 1 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (6) , 103664
Coronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT Roundtable
- 1 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (6) , 103664
Open AccessCoronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT Roundtable
- Open Access
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102506
Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102506
Open AccessArtificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision
- 1 August 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (8) , e014145
Debulking Effect of Orbital Atherectomy for Calcified Nodule Assessed by Optical Coherence Tomography
- 1 August 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (8) , e014145
Debulking Effect of Orbital Atherectomy for Calcified Nodule Assessed by Optical Coherence Tomography
- 24 July 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 104 (3) , 425-436
Paclitaxel‐coated versus sirolimus‐coated balloon angioplasty for coronary artery disease: A systematic review and meta‐analysis
Background: Although use of sirolimus‐based analogs has shown superiority over paclitaxel in drug‐eluting stents, the relative efficacy of these two agents released from drug‐coated balloons (DCB) is unclear. The present meta‐analysis is aimed to compare outcomes after percutaneous coronary intervention (PCI) with paclitaxel‐coated balloons (PCB) versus sirolimus‐coated balloons (SCB) for either in‐stent restenosis or native de novo lesions.Methods: The study outcomes were 1) target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction, or target lesion revascularization, and 2) follow‐up angiographic parameters including late lumen loss (LLL), diameter stenosis, and minimal lumen diameter (MLD). Pooled odds ratios (OR) and weighted mean differences (WMD) with 95% confidence intervals (CI) were calculated by using random‐effects models.Results: A search of PubMed, EMBASE, and Cochrane Library from their inception to January 2024 identified five randomized clinical trials and three observational studies with a total of 1861 patients (889 in PCB and 972 in SCB groups). During 9–12 months of follow‐up, there was no significant difference in TLF (OR 1.01, 95% CI 0.75–1.35) between the two groups. On follow‐up angiography at 6–9 months, MLD (WMD 0.10, 95% CI 0.02–0.17) was larger in PCB but there was no statistically significant difference in LLL (WMD −0.11, 95% CI −0.23–0.02) and diameter stenosis (WMD −3.33, 95% CI −8.11–1.45).Conclusions: Among patients undergoing DCB‐only PCI, the risk of TLF was similar during 9–12 months of follow‐up after PCB and SCB treatment. However, the MLD was larger favoring PCB over SCB on follow‐up angiography.
- 24 July 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 104 (3) , 425-436
Paclitaxel‐coated versus sirolimus‐coated balloon angioplasty for coronary artery disease: A systematic review and meta‐analysis
Background: Although use of sirolimus‐based analogs has shown superiority over paclitaxel in drug‐eluting stents, the relative efficacy of these two agents released from drug‐coated balloons (DCB) is unclear. The present meta‐analysis is aimed to compare outcomes after percutaneous coronary intervention (PCI) with paclitaxel‐coated balloons (PCB) versus sirolimus‐coated balloons (SCB) for either in‐stent restenosis or native de novo lesions.Methods: The study outcomes were 1) target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction, or target lesion revascularization, and 2) follow‐up angiographic parameters including late lumen loss (LLL), diameter stenosis, and minimal lumen diameter (MLD). Pooled odds ratios (OR) and weighted mean differences (WMD) with 95% confidence intervals (CI) were calculated by using random‐effects models.Results: A search of PubMed, EMBASE, and Cochrane Library from their inception to January 2024 identified five randomized clinical trials and three observational studies with a total of 1861 patients (889 in PCB and 972 in SCB groups). During 9–12 months of follow‐up, there was no significant difference in TLF (OR 1.01, 95% CI 0.75–1.35) between the two groups. On follow‐up angiography at 6–9 months, MLD (WMD 0.10, 95% CI 0.02–0.17) was larger in PCB but there was no statistically significant difference in LLL (WMD −0.11, 95% CI −0.23–0.02) and diameter stenosis (WMD −3.33, 95% CI −8.11–1.45).Conclusions: Among patients undergoing DCB‐only PCI, the risk of TLF was similar during 9–12 months of follow‐up after PCB and SCB treatment. However, the MLD was larger favoring PCB over SCB on follow‐up angiography.
- 19 April 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 103 (6) , 833-842
Prevalence and anatomical factors associated with stent under‐expansion in non‐severely calcified lesions
Background: Stent underexpansion, typically related to lesion calcification, is the strongest predictor of adverse events after percutaneous coronary intervention (PCI). Although uncommon, underexpansion may also occur in non‐severely calcified lesions.Aim: We sought to identify the prevalence and anatomical characteristics of underexpansion in non‐severely calcified lesions.Methods: We included 993 patients who underwent optical coherence tomography‐guided PCI of 1051 de novo lesions with maximum calcium arc 2.Results: Underexpansion was observed in 3.6% of non‐heavily calcified lesions (38/1051). Pre‐stent maximum calcium arc and thickness were greater in lesions with versus without underexpansion (median 119° vs. 85°, p = 0.002; median 0.95 mm vs. 0.78 mm, p = 0.008). NR was also more common in lesions with underexpansion (44.7% vs. 24.5%, p = 0.007). In the multivariable logistic regression model, larger and thicker eccentric calcium, mid left anterior descending artery (LAD) location, and NR were associated with underexpansion in non‐severely calcified lesions. The rate of underexpansion was especially high (30.7%) in lesions exhibiting all three morphologies. Two‐year TLF tended to be higher in underexpanded versus non‐underexpanded stents (9.7% vs. 3.7%, unadjusted hazard ratio [95% confidence interval] = 3.02 [0.92, 9.58], p = 0.06).Conclusion: Although underexpansion in the absence of severe calcium (<180°) is uncommon, mid‐LAD lesions with NR and large and thick eccentric calcium were associated with underexpansion.
- 19 April 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 103 (6) , 833-842
Prevalence and anatomical factors associated with stent under‐expansion in non‐severely calcified lesions
Background: Stent underexpansion, typically related to lesion calcification, is the strongest predictor of adverse events after percutaneous coronary intervention (PCI). Although uncommon, underexpansion may also occur in non‐severely calcified lesions.Aim: We sought to identify the prevalence and anatomical characteristics of underexpansion in non‐severely calcified lesions.Methods: We included 993 patients who underwent optical coherence tomography‐guided PCI of 1051 de novo lesions with maximum calcium arc 2.Results: Underexpansion was observed in 3.6% of non‐heavily calcified lesions (38/1051). Pre‐stent maximum calcium arc and thickness were greater in lesions with versus without underexpansion (median 119° vs. 85°, p = 0.002; median 0.95 mm vs. 0.78 mm, p = 0.008). NR was also more common in lesions with underexpansion (44.7% vs. 24.5%, p = 0.007). In the multivariable logistic regression model, larger and thicker eccentric calcium, mid left anterior descending artery (LAD) location, and NR were associated with underexpansion in non‐severely calcified lesions. The rate of underexpansion was especially high (30.7%) in lesions exhibiting all three morphologies. Two‐year TLF tended to be higher in underexpanded versus non‐underexpanded stents (9.7% vs. 3.7%, unadjusted hazard ratio [95% confidence interval] = 3.02 [0.92, 9.58], p = 0.06).Conclusion: Although underexpansion in the absence of severe calcium (<180°) is uncommon, mid‐LAD lesions with NR and large and thick eccentric calcium were associated with underexpansion.
- Open Access
- 25 August 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (6) , 101126
Intravascular Lithotripsy for Calcified Left Main Artery Disease
- 25 August 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (6) , 101126
Open AccessIntravascular Lithotripsy for Calcified Left Main Artery Disease